Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.0B | 3.2B | 4.1B | 3.6B |
| Cost of revenue | 357M | 335M | 388M | 362M |
| Gross profit | 2.6B | 2.8B | 3.7B | 3.2B |
| Operating expense | ||||
| Research & development | 320M | 322M | 320M | 331M |
| Selling general and admin | 2.1B | 2.0B | 2.3B | 2.2B |
| Other operating expenses | — | — | — | — |
| Operating income | -44M | 356M | 860M | 496M |
| Non operating interest income | ||||
| Income | 54M | 50M | 67M | 67M |
| Expense | 58M | 62M | 61M | 61M |
| Other income expense | -169M | -9M | 8M | -14M |
| Pretax income | -217M | 335M | 874M | 488M |
| Tax provision | -20M | 34M | 190M | 113M |
| Net income | -197M | 301M | 684M | 375M |
| Basic EPS | -1.6 | 2.3 | 5.3 | 2.9 |
| Diluted EPS | -1.6 | 2.2 | 5.0 | 2.8 |
| Basic average shares | 6.6M | 6.6M | 6.7M | 6.8M |
| Diluted average shares | 6.6M | 7.0M | 7.0M | 7.1M |
| EBITDA | 227M | 618M | 1.1B | 768M |
| Net income from continuing op. | -197M | 301M | 684M | 375M |
| Minority interests | -3M | -2M | 0 | 11M |
| Preferred stock dividends | — | — | — | — |